Mahaney Paige 4
4 · C4 Therapeutics, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Mahaney Paige
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-02-14+28,200→ 105,000 total - Award
Stock Option (Right to Buy)
2025-02-14+42,400→ 42,400 totalExercise: $3.18Exp: 2035-02-13→ Common Stock (42,400 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.
- [F2]The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.